Dziedziczne podłoże czerniaka – wyniki badań własnych na tle piśmiennictwa

by Tadeusz Dębniak, Romuald Maleszka, Jan Lubiński
Published 2011-07-01

Homozygous deletion of CDKN2A by fluorescence in situ hybridization is prognostic in grade 4, but not grade 2 or 3, IDH-mutant astrocytomas

by Daniel F. Marker, Thomas M. Pearce
Published 2020-10-01

ASSOCIATION OF CERTAIN SINGLE NUCLEOTIDE POLYMORPHISM GENES OF APOPTOSIS SYSTEM WITH A RISK OF DEVELOPMENT OF COLORECTAL CANCER IN RUSSIAN POPULATION

by M. Kh. Alyeva, S. Ya. Zverev, I. V. Feldblyum, E. Yu. Noskova, A. O. Kanina, N. I. Markovich
Published 2016-10-01

Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma

by Andrea Forschner, Tobias Sinnberg, Tobias Sinnberg, Gabi Mroz, Christopher Schroeder, Christian Philipp Reinert, Sergios Gatidis, Michael Bitzer, Thomas Eigentler, Claus Garbe, Heike Niessner, Martin Röcken, Martin Röcken, Cristiana Roggia, Sorin Armeanu-Ebinger, Olaf Riess, Olaf Riess, Sven Mattern, Dominik Nann, Irina Bonzheim
Published 2021-03-01

Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report

by Vallari Shah, Kevin D. Boyd, Richard S. Houlston, Martin F. Kaiser
Published 2017-11-01

Pesquisa de mutações no gene CDKN2A em pacientes com critérios clínicos de melanoma hereditário.

by Jair Huber
Published 2004

Pesquisa de mutações no gene CDKN2A em pacientes com critérios clínicos de melanoma hereditário.

by Huber, Jair
Published 2004

Discovering the mechanism and involvement of the methylation of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and its special locus region in gastric cancer

by Jiye Xu, Ning Li, Wenying Deng, Suxia Luo
Published 2021-01-01

Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?

by Wu C, Yang P, Liu B, Tang Y
Published 2020-03-01

Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study

by Milena Casula, Panagiotis Paliogiannis, Fabrizio Ayala, Vincenzo De Giorgi, Ignazio Stanganelli, Mario Mandalà, Maria Colombino, Antonella Manca, Maria Cristina Sini, Corrado Caracò, Paolo Antonio Ascierto, Rosanna Rita Satta, Melanoma Unit of Sassari (MUS), Amelia Lissia, Antonio Cossu, Giuseppe Palmieri, for the Italian Melanoma Intergroup (IMI)
Published 2019-08-01

Characterizing the Roles of BRAF, PTEN and Cdkn2a in Novel Mouse Models of Melanoma Formation and Progression

by Curley, David
Published 2008

The prognostic significance of p16 expression pattern in diffuse gliomas

by Jin Woo Park, Jeongwan Kang, Ka Young Lim, Hyunhee Kim, Seong-Ik Kim, Jae Kyung Won, Chul-Kee Park, Sung-Hye Park
Published 2021-03-01

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer

by Sikic D, Taubert H, Breyer J, Eckstein M, Weyerer V, Keck B, Kubon J, Otto W, Worst TS, Kriegmair MC, Erben P, Hartmann A, Wullich B, Wirtz RM, Wach S
Published 2021-08-01

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma

by Yusuke Funakoshi, Nobuhiro Hata, Kosuke Takigawa, Hideyuki Arita, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Aki Sako, Toru Umehara, Tadamasa Yoshitake, Osamu Togao, Akio Hiwatashi, Koji Yoshimoto, Toru Iwaki, Masahiro Mizoguchi
Published 2021-05-01

Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts

by Toru Umehara, Hideyuki Arita, Ema Yoshioka, Tomoko Shofuda, Daisuke Kanematsu, Manabu Kinoshita, Yoshinori Kodama, Masayuki Mano, Naoki Kagawa, Yasunori Fujimoto, Yoshiko Okita, Masahiro Nonaka, Kosuke Nakajo, Takehiro Uda, Naohiro Tsuyuguchi, Junya Fukai, Koji Fujita, Daisuke Sakamoto, Kanji Mori, Haruhiko Kishima, Yonehiro Kanemura
Published 2019-06-01

Characterization of <it>CDKN2A</it>(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing

by Bihl Michel P, Foerster Anja, Lugli Alessandro, Zlobec Inti
Published 2012-08-01

CDKN2A Gene Expression as a Potential Aging Biomarker in Dogs

by Sára Sándor, Kitti Tátrai, Kitti Tátrai, Kálmán Czeibert, Balázs Egyed, Enikő Kubinyi
Published 2021-04-01

Untersuchung von Promotormethylierungen des p16-Gens im Atemkondensat von Patienten mit Bronchialkarzinom und Vergleich mit Tumorpräparaten

by Grabner, Enrico
Published 2015

CDKN2A-Inactivated Pancreatic Ductal Adenocarcinoma Exhibits Therapeutic Sensitivity to Paclitaxel: A Bioinformatics Study

by Jiunn-Chang Lin, Tsang-Pai Liu, Pei-Ming Yang
Published 2020-12-01

Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma

by Lucia Cottone, Nadia Eden, Inga Usher, Patrick Lombard, Hongtao Ye, Lorena Ligammari, Daniel Lindsay, Sebastian Brandner, Jože Pižem, Nischalan Pillay, Roberto Tirabosco, Fernanda Amary, Adrienne M Flanagan
Published 2020-04-01